Home
Conditions
Acute Myeloid Leukemia (AML)

Clinical trial condition

Acute Myeloid Leukemia (AML)

Explore clinical trials studying Acute Myeloid Leukemia (AML). Study availability and eligibility vary by location and protocol.

146 public trials 43 recruiting studies

Refine in advanced search Browse all conditions

Acute Myeloid Leukemia (AML) trial results

Not Yet Recruiting

Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia

NCT07486726

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Shanghai, China

Shanghai Jing'an District Beizhan Hospital Shanghai, China

Shanghai Traditional Chinese Medicine Hospital Shanghai, China

Tongren Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China

View Trial Details

Not Yet Recruiting

Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker

NCT07060001

Conditions: Acute Myeloid Leukaemia (AML), Acute Myeloid Leukemia (AML), Hematologic Diseases, +6 more
Locations: Houston Methodist Neal Cancer Center Houston, Texas, United States

View Trial Details

Not Yet Recruiting

A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)

NCT07053020

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not Yet Recruiting

A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloid Leukemia

NCT07423104

Conditions: Acute Myeloid Leukemia (AML), Disease Attributes, Hematologic Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Harmonized Clinical and Biological Database for Integrated Research Into the Management of Pediatric Acute Myeloid Leukemia

NCT07150676

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia

NCT07087847

Conditions: ALL (Acute B-Lymphoblastic Leukemia), Acute Leukemia, Acute Leukemia Refractory, +9 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Azacitidine Combined with Donor Lymphocyte Infusion for Acute Myeloid Leukemia Post-transplant Relapse Prevention.

NCT06754540

Conditions: Acute Myeloid Leukemia (AML), Disease Attributes, Hematologic Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia

NCT06702098

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Guangzhou Ruixin Biotechnology Co., Ltd Guangzhou, Guangdong Province, China, China

View Trial Details

Not Yet Recruiting

Molecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid Leukemia

NCT06652685

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, China

View Trial Details

Not Yet Recruiting

A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined with Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.

NCT06641648

Conditions: Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia (AML) Relapse, Disease Attributes, +11 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia (AML) trial results

Related conditions